(Q38051718)

27 August 2017

title

The role of Thymoglobulin induction in kidney transplantation: an update (English)

1 reference

27 August 2017

main subject

kidney transplantation

1 reference

5

Yvon Lebranchu

0 references

author name string

Georges Mourad

1

1 reference

27 August 2017

Emmanuel Morelon

2

1 reference

27 August 2017

Christian Noël

3

1 reference

27 August 2017

Denis Glotz

4

1 reference

27 August 2017

publication date

1 September 2012

1 reference

27 August 2017

published in

Clinical Transplantation

1 reference

27 August 2017

volume

26

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

E450-64

1 reference

Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology

27 August 2017

cites work

1 reference

Heterologous antilymphocyte globulin

21 January 2018

1 reference

Rabbit antithymocyte globulin versus basiliximab in renal transplantation

21 January 2018

1 reference

Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients

21 January 2018

1 reference

Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.

21 January 2018

1 reference

Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids

21 January 2018

1 reference

Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion

21 January 2018

1 reference

Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin

21 January 2018

1 reference

A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells

21 January 2018

1 reference

Acute rejection and chronic nephropathy: a systematic review of the literature.

21 January 2018

1 reference

Clinical evaluation of equine antithymocyte globulin in recipients of renal allografts: Analysis of survival, renal function, rejection, histocompatibility, and complications.

21 January 2018

1 reference

Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors

21 January 2018

1 reference

Cyclosporin A in patients receiving renal allografts from cadaver donors

21 January 2018

1 reference

Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression

21 January 2018

1 reference

A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients

21 January 2018

1 reference

Treatment of first acute rejection episode: systematic review of level I evidence

21 January 2018

1 reference

Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation

21 January 2018

1 reference

A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results

21 January 2018

1 reference

A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring

21 January 2018

1 reference

CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.

21 January 2018

1 reference

Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression

21 January 2018

1 reference

Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients

21 January 2018

1 reference

Rabbit antithymocyte globulin is more beneficial in standard kidney than in extended donor recipients

21 January 2018

1 reference

Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: application of statistical approaches to reduce bias in observational comparisons

21 January 2018

1 reference

Alemtuzumab induction in renal transplantation

21 January 2018

1 reference

Outcomes in African-Americans vs. Caucasians using thymoglobulin or interleukin-2 receptor inhibitor induction: analysis of USRDS database

21 January 2018

1 reference

Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience

21 January 2018

1 reference

Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy

21 January 2018

1 reference

Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation

21 January 2018

1 reference

Ischemia-reperfusion and immediate T cell responses

21 January 2018

1 reference

A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1

21 January 2018

1 reference

Delayed graft function: risk factors and implications for renal allograft survival

21 January 2018

1 reference

Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis

21 January 2018

1 reference

Long-term immunosuppression, without maintenance prednisone, after kidney transplantation

21 January 2018

1 reference

A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis

21 January 2018

1 reference

A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation

21 January 2018

1 reference

Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation?

21 January 2018

1 reference

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

21 January 2018

1 reference

Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy

21 January 2018

1 reference

Sirolimus Versus Cyclosporine in Kidney Recipients Receiving Thymoglobulin®, Mycophenolate Mofetil and a 6-Month Course of Steroids

21 January 2018

1 reference

Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids

21 January 2018

1 reference

Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus

21 January 2018

1 reference

Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation

21 January 2018

1 reference

Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER study

21 January 2018

1 reference

Reduced exposure to calcineurin inhibitors in renal transplantation

21 January 2018

1 reference

The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients

21 January 2018

1 reference

Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy

21 January 2018

1 reference

Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation

21 January 2018

1 reference

Rabbit antithymocyte globulin induction therapy in adult renal transplantation

21 January 2018

1 reference

Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report

21 January 2018

1 reference

Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring

21 January 2018

1 reference

Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients

21 January 2018

1 reference

Continuous infusion of thymoglobulin for induction therapy in pediatric heart transplant recipients; experience and outcomes with a novel strategy for administration

21 January 2018

1 reference

Analysis of infusion-site reactions in renal transplant recipients receiving peripherally administered rabbit antithymocyte globulin as compared with basiliximab

21 January 2018

1 reference

Administration of rabbit antithymocyte globulin (thymoglobulin) in ambulatory renal-transplant patients

21 January 2018

1 reference

Deep vein thrombosis during rabbit antithymocyte globulin administration.

21 January 2018

1 reference

Peripheral administration of thymoglobulin for induction therapy in pancreas transplantation

21 January 2018

1 reference

Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: a single-center report

21 January 2018

1 reference

Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression

21 January 2018

1 reference

Comparison of polyclonal induction agents in pediatric renal transplantation

21 January 2018

1 reference

Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation

21 January 2018

1 reference

Serum sickness after treatment with rabbit antithymocyte globulin in kidney transplant recipients with previous rabbit exposure

21 January 2018

1 reference

Immune reconstitution following rabbit antithymocyte globulin.

21 January 2018

1 reference

Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine.

21 January 2018

1 reference

Infectious complications of antilymphocyte therapies in solid organ transplantation

21 January 2018

1 reference

Cytomegalovirus reactivation and tumour necrosis factor

21 January 2018

1 reference

Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States

21 January 2018

1 reference

An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States

21 January 2018

1 reference

Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication

21 January 2018

1 reference

Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients

21 January 2018

1 reference

Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression

21 January 2018

1 reference

Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients

21 January 2018

1 reference

Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation

21 January 2018

1 reference

Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation

21 January 2018

1 reference

Lymphoproliferative disease after renal transplantation in Australia and New Zealand

21 January 2018

1 reference

Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab.

21 January 2018

1 reference

A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice

21 January 2018

1 reference

A novel clinically relevant approach to tip the balance toward regulation in stringent transplant model.

21 January 2018

1 reference

Rabbit anti-rat thymocyte immunoglobulin preserves renal function during ischemia/reperfusion injury in rat kidney transplantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CTR.12021

1 reference

27 August 2017

1 reference